Who Are We?


As a technology solution provider in the field of life sciences, Taimei Technology is dedicated to propel biopharmaceutical industry development through state-of-the-art information technology, with focus in the field of clinical research and pharmacovigilance. In 2018, Taimei Technology secured D-round investment of 300 million yuan from world-leading venture capital firms.

At present, the headquarters of Taimei Technology is located in Jiaxing with offices in Shanghai and Beijing, with full-time staff distributed across nearly 20 cities in the country for regional work support. It has more than 300 employees with professional experience in the fields of clinical research, pharmacovigilance, data management, statistical analysis and IT. The core management team has rich and extensive working experience in the pharmaceutical industry, and have served as senior management in well-known global and local leading enterprises.

Taimei Technology has developed AIMS (Clinical Trial Management System, CTMS), eCollect® (electronic data capture system, EDC), eBalance (interactive web response system, IWRS), eReport® (electronic patient report outcome system, ePRO), eArchives® (electronic trial master file system, eTMF), eSafety (pharmacovigilance system, PV), eCollege® (training management system, TMS), eImage (medical imaging reading system, MIRS) and other core products, with support of mobile and desktop-end applications for complete data synchrony across products on Taimei Cloud platform. Professional design philosophy and normative technical standards are the principles of Taimei Technology product development, conforming to CDISC standard, Title 21 CFR Part 11 fundamental system standard and GAMP5 system validation standard. Taimei Technology is also the first in the industry to obtain full-range ISO certifications, including ISO 9001 Quality Management Certification, ISO 27001 Information Security Management Certification and ISO 20001 IT Service Management Certification. At the same time, Taimei Technology is the first member and registered supplier of CDISC, as well as the only only one obtaining WHO-DRUG system provider certified by WHO-UMC in China.

On the foundation of our products, Taimei Technology offers clinical research solutions, document management solutions and pharmacovigilance solutions to provide end-to-end services, effectively helping enterprises improve quality and efficiency of clinical research, reducing research and operation costs for faster time-to-market in drug development process.

Taimei Technology clients include traditional pharmaceutical enterprises, innovative pharmaceutical enterprises, CRO and research institutes. To date, Taimei Technology has established close collaborations and strategic partnerships with over 200 leading local and global pharmaceutical companies and CROs.


 

Life Science Field

Life Science Field

Focused on life sciences,With deep insights within clinical research and pharmacovigilance

Cloud

Cloud

Advanced cloud-based technology Adopted to develop professional and leading SaaS

Solution

Solution

Professional system + professional services
From planning to implementation of comprehensive coverage

Provider

Provider

Professional service
Real-time support, fast response

  

Professional service from professional team

In Taimei Medical Technology, 280+ staff are committed to providing you professional services based on our 

over 15 + years of professional experiences in the industry.

40% + employees have clinical research or pharmacovigilance experience



230+ staff                 15 + years of professional experiences                 40% + professional employees

 


Our Milestone


Committed to the application of modern information technology in health care, we are developing a series of leading cloud-based mobile technology products.
We are specializing in software design, production, implementation and consulting to improve the efficiency and quality of the industry.

 未标题-11.jpg


Our Mission and Values


Website Keywords

Accelerate New Drug Time-To-Marketand Advance Life Sciences


Leading the Industry with Strict and Compliant 

Product Design Standards

 

The verification in compliance with national standards

Title 21 CFR Part 11 (International Basic Standards) 

CDISC (Data Interchange Standard) 

GAMP5 (System Verification Standard)

The first CDISC member and registered supplier in China

The first in the industry to fully pass all certification

ISO 9001 Quality Management Certification 

ISO 27001 Information Security Management Certification 

ISO 20001 IT Service Management Certification

Online coding system certified by WHO 

MedDRA medical terminology coding dictionary 

WHO-Drug Drug Coding Dictionary